Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of Gemcitabine and Imatinib in Malignant Pleural Mesothelioma
2014-002876-10Phase 2Active
- Sponsor
- Humanitas Research Hospital
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of imatinib and gemcitabine in pleural mesothelioma, sponsored by Humanitas Research Hospital. Primary endpoint: Anti-tumor activity of imatinib in combination. Started Sep 2014; status: active.
02
Drugs
imatinibgemcitabine
03
Conditions
pleural mesothelioma
Beyond the preview
Go deeper on 2014-002876-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002876-10.